Redefining Hope: The Multidisciplinary Approach to Recurrent Brain Tumors

OPD

MON - Sat: 11:00 AM - 4:00 PM

Redefining Hope: The Multidisciplinary Approach to Recurrent Brain Tumors

Receiving news that a primary brain tumor has recurred after initial treatment is profoundly distressing. However, within the realm of modern neuro-oncology, a tumor recurrence is not an endpoint; it is an immediate prompt for aggressive, highly tailored neurosurgical and oncological management.

Because malignant tumors alter their genetic blueprint over time, a recurrent lesion must be evaluated and treated with entirely fresh clinical parameters.

Advanced Modalities for Re-Resection

• Fluorescence-Guided Surgery (5-ALA): The patient ingests a targeted compound pre-operatively that causes malignant cells to emit a bright pink fluorescence under specialized microscopic light, sharply differentiating tumor margins from healthy cortical tissue.
• Intraoperative Neuro-Navigation:Updated MRI models compensate for structural shifts from previous surgeries, safely steering instruments away from critical neurovascular structures.
• Genomic Profiling: Excised recurrent tissue is immediately sequenced for molecular subtyping, unlocking pathways for highly specific, targeted adjuvant immunotherapies.

Clinical Takeaway

Managing recurrence requires a multidisciplinary tumor board approach. Combining advanced fluorescence-guided resection with personalized molecular therapy provides a strategic framework to target the disease while preserving the patient’s neurological baseline.

OPD

Call us

email us